Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chun-Jen Liu

Showing results (191-200 of 400) with videos related to

Pageof 40
Sort By:
Medicine|March 1, 2019
Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaqueLo-Yip Yu, Kuang-Chun Hu, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|July 10, 2024
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virusYu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 21, 2024
Serological responses to COVID-19 vaccination in patients with chronic liver diseasesYu-Shan Huang, Szu-Min Hsieh, Feng-Chiao Tsai, et al.
Journal of the National Cancer Institute|February 17, 2005
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in menMing-Whei Yu, Shiou-Hwei Yeh, Pei-Jer Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2021
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized TrialPin-Nan Cheng, Chun-Jen Liu, Chi-Yi Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisHwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
The Journal of Infectious Diseases|January 5, 2018
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir TherapyTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
Journal of Hepatocellular Carcinoma|April 18, 2022
Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis BRei-Chi Hsueh, Wan-Jung Wu, Chih-Lin Lin, et al.
Hepatology International|March 20, 2015
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Pageof 40

Showing results (191-200 of 400) with videos related to

Sort By:
Pageof 40
Medicine|March 1, 2019
Helicobacter pylori infection combined with non-alcoholic fatty liver disease increase the risk of atherosclerosis: Focus in carotid artery plaqueLo-Yip Yu, Kuang-Chun Hu, Chun-Jen Liu, et al.
Journal of Gastroenterology and Hepatology|July 10, 2024
Serum Mac-2 binding protein glycosylation isomer dynamics in patients achieving sustained virologic response for hepatitis C virusYu-Ping Chang, Chen-Hua Liu, Chiuan-Bo Huang, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|June 21, 2024
Serological responses to COVID-19 vaccination in patients with chronic liver diseasesYu-Shan Huang, Szu-Min Hsieh, Feng-Chiao Tsai, et al.
Journal of the National Cancer Institute|February 17, 2005
Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in menMing-Whei Yu, Shiou-Hwei Yeh, Pei-Jer Chen, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 5, 2021
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized TrialPin-Nan Cheng, Chun-Jen Liu, Chi-Yi Chen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 15, 2013
Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneouslyHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 25, 2015
Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of Hepatitis B Virus DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without CirrhosisHwai-I Yang, Tai-Chung Tseng, Jessica Liu, et al.
The Journal of Infectious Diseases|January 5, 2018
Distinct Relapse Rates and Risk Predictors After Discontinuing Tenofovir and Entecavir TherapyTung-Hung Su, Hung-Chih Yang, Tai-Chung Tseng, et al.
Journal of Hepatocellular Carcinoma|April 18, 2022
Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis BRei-Chi Hsueh, Wan-Jung Wu, Chih-Lin Lin, et al.
Hepatology International|March 20, 2015
Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infectionHuei-Ru Cheng, Jia-Horng Kao, Hui-Lin Wu, et al.
Pageof 40